TFG Asset Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,903,662
| Closed | -$27.2M | – | 31 |
|
|
2023
Q4 | $27.2M | Hold |
1,903,662
| – | – | 6.54% | 4 |
|
|
2023
Q3 | $29.4M | Hold |
1,903,662
| – | – | 5.37% | 5 |
|
|
2023
Q2 | $29.9M | Hold |
1,903,662
| – | – | 4.04% | 7 |
|
|
2023
Q1 | $31.4M | Hold |
1,903,662
| – | – | 4.2% | 8 |
|
|
2022
Q4 | $29.7M | Buy |
1,903,662
+220,828
| +13% | +$3.44M | 4.25% | 8 |
|
|
2022
Q3 | $21.8M | Buy |
1,682,834
+407,178
| +32% | +$5.28M | 2.63% | 13 |
|
|
2022
Q2 | $17.9M | Hold |
1,275,656
| – | – | 1.23% | 24 |
|
|
2022
Q1 | $18.3M | Hold |
1,275,656
| – | – | 0.83% | 31 |
|
|
2021
Q4 | $17.4M | Sell |
1,275,656
-71,277
| -5% | -$971K | 1.05% | 25 |
|
|
2021
Q3 | $22.1M | Hold |
1,346,933
| – | – | 1.35% | 18 |
|
|
2021
Q2 | $22.7M | Buy |
1,346,933
+757,543
| +129% | +$12.7M | 1.24% | 20 |
|
|
2021
Q1 | $10.8M | Sell |
589,390
-853,662
| -59% | -$15.6M | 0.77% | 23 |
|
|
2020
Q4 | $26.3M | Buy |
1,443,052
+789,390
| +121% | +$14.4M | 1.76% | 13 |
|
|
2020
Q3 | $11.7M | Hold |
653,662
| – | – | 1.07% | 22 |
|
|
2020
Q2 | $11.7M | Buy |
653,662
+256,000
| +64% | +$4.59M | 1.56% | 16 |
|
|
2020
Q1 | $6.04M | Hold |
397,662
| – | – | 1.04% | 19 |
|
|
2019
Q4 | $7.85M | Hold |
397,662
| – | – | 1.17% | 22 |
|
|
2019
Q3 | $6.84M | Buy |
397,662
+218,700
| +122% | +$3.76M | 1.22% | 20 |
|
|
2019
Q2 | $3.17M | Buy |
178,962
+105,301
| +143% | +$1.86M | 0.46% | 34 |
|
|
2019
Q1 | $1.5M | Buy |
+73,661
| New | +$1.5M | 0.19% | 43 |
|